Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.

Sixty-six replacing growth-type early lung adenocarcinomas, measuring 2 cm or less across their greatest dimension, were used to investigate allelic losses at eight loci on the eight chromosomes carrying the principal cancer-associated genes. In total, 2 (16.7%) of 12 type A tumors (localized bronchioloalveolar carcinoma, LBAC) and 11 (39.3%) of 28 type B tumors (LBAC with alveolar collapse), which correspond to early lung adenocarcinomas including cancers in situ, showed allelic losses in one or more of the regions examined. In contrast, 25 (96.2%) of 26 type C tumors (LBAC with active fibroblastic proliferation), which correspond to small but advanced tumors, showed allelic losses in one or more regions. The change in histology from type A to type C was characterized by a significant rise in the incidence of allelic losses (P < 0.01). Deletions of 3p, 17p, 18q, and 22q increased significantly during malignant progression. In type C tumors that showed heterogeneous histological features, the tumor cells in the central fibrotic areas exhibited more allelic losses than those in the peripheral bronchioloalveolar growths and were, therefore, considered to have progressed to a more advanced stage than the tumor cells in the peripheral regions.

[1]  M. Noguchi,et al.  Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. , 2000, Cancer research.

[2]  S. Lam,et al.  High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. , 2000, Cancer research.

[3]  S. Hirohashi,et al.  Comparative allelotype of early and advanced stage non‐small cell lung carcinomas , 1996, Genes, chromosomes & cancer.

[4]  J. Minna,et al.  Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. , 1999, Journal of the National Cancer Institute.

[5]  Setsuo Hirohashi,et al.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis , 1995 .

[6]  Y. Ishikawa,et al.  Association of Loss of Heterozygosity at the p53 Locus with Chemoresistance in Osteosarcomas , 1998, Japanese journal of cancer research : Gann.

[7]  W. Stolz,et al.  Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas , 1999, Archives of Dermatological Research.

[8]  M. Noguchi,et al.  Application of the p53 and K‐ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas , 2000, Cancer.

[9]  Y. Shimosato [Histological Typing of Lung and Pleural Tumors (3rd edition, 1999): Malignant epithelial tumors]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[10]  S. Hirohashi,et al.  A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. , 1998, Cancer research.

[11]  Peter A. Jones,et al.  Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer , 1998, Oncogene.

[12]  J. Minna,et al.  Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma , 1999, Oncogene.

[13]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[14]  中山 治彦 Clonal growth of atypical adenomatous hyperplasia of the lung : cytofluorometric analysis of nuclear DNA content , 1993 .

[15]  J. Jen,et al.  Detailed deletion mapping at chromosome 9p21 in non‐small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization , 1997, International journal of cancer.

[16]  R. Rosell,et al.  Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  穴見 洋一 Amplotyping of microdissected, methanol-fixed lung carcinoma by arbitrarily primed polymerase chain reaction , 2000 .